240
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Associations between statin use and progression in men with prostate cancer treated with primary androgen deprivation therapy

ORCID Icon, , , ORCID Icon, ORCID Icon, & show all
Pages 464-469 | Received 15 Mar 2017, Accepted 19 Jul 2017, Published online: 23 Aug 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Lauri Rantaniemi, Teuvo L. J. Tammela, Paula Kujala & Teemu J. Murtola. (2018) Blood cholesterol, tumor clinical characteristics and risk of prostate cancer progression after radical prostatectomy. Scandinavian Journal of Urology 52:4, pages 269-276.
Read now

Articles from other publishers (8)

Viranda H. Jayalath, Roderick Clark, Katherine Lajkosz, Rouhi Fazelzad, Neil E. Fleshner, Laurence H. Klotz & Robert J. Hamilton. (2022) Statin Use and Survival Among Men Receiving Androgen-Ablative Therapies for Advanced Prostate Cancer. JAMA Network Open 5:11, pages e2242676.
Crossref
Anthony M. Joshua, Andrew Armstrong, Megan Crumbaker, Howard I. Scher, Johann de Bono, Bertrand Tombal, Maha Hussain, Cora N. Sternberg, Silke Gillessen, Joan Carles, Karim Fizazi, Ping Lin, William Duggan, Jennifer Sugg, David Russell & Tomasz M. Beer. (2022) Statin and metformin use and outcomes in patients with castration-resistant prostate cancer treated with enzalutamide: A meta-analysis of AFFIRM, PREVAIL and PROSPER. European Journal of Cancer 170, pages 285-295.
Crossref
Emma L. Craig, Konrad H. Stopsack, Emma Evergren, Linda Z. Penn, Stephen J. Freedland, Robert J. Hamilton & Emma H. Allott. (2022) Statins and prostate cancer—hype or hope? The epidemiological perspective. Prostate Cancer and Prostatic Diseases 25:4, pages 641-649.
Crossref
Yu-Chen Hou & Yu-Hsuan Shao. (2022) The Effects of Statins on Prostate Cancer Patients Receiving Androgen Deprivation Therapy or Definitive Therapy: A Systematic Review and Meta-Analysis. Pharmaceuticals 15:2, pages 131.
Crossref
A. I. Peltomaa, P. Raittinen, K. Talala, K. Taari, T. L. J. Tammela, A. Auvinen & T. J. Murtola. (2021) Prostate cancer prognosis after initiation of androgen deprivation therapy among statin users. A population-based cohort study. Prostate Cancer and Prostatic Diseases 24:3, pages 917-924.
Crossref
Hui Yang, Lizhen Pang, Xiaopeng Hu, Wei Wang, Bifang Xu, Xiaodong Zhang & Lihong Liu. (2020) The effect of statins on advanced prostate cancer patients with androgen deprivation therapy or abiraterone/enzalutamide: A systematic review and meta‐analysis. Journal of Clinical Pharmacy and Therapeutics 45:3, pages 488-495.
Crossref
Tian Wang, Dexing Wang, Lian Zhang, Ping Yang, Jing Wang, Qi Liu, Fei Yan & Feng Lin. (2019) The TGFβ-miR-499a-SHKBP1 pathway induces resistance to EGFR inhibitors in osteosarcoma cancer stem cell-like cells. Journal of Experimental & Clinical Cancer Research 38:1.
Crossref
Szu-Yuan Wu, Su-Chen Fang, Hung-Jen Shih, Yu-Chin Wen & Yu-Hsuan Joni Shao. (2019) Mortality associated with statins in men with advanced prostate cancer treated with androgen deprivation therapy. European Journal of Cancer 112, pages 109-117.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.